Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now full pipeline small index

Sleeve Gastrectomy: full-pipeline trial registry

5 of 9 indexed Sleeve Gastrectomy trials are currently recruiting.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 5 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Sleeve Gastrectomy: 9 US clinical trials tracked, 5 recruiting.

Sleeve Gastrectomy is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Brigham and Women's Hospital, running 3 of these trials.

Enrollment posture brief

Registry condition sleeve-gastrectomy

OPEN 5 | RECR 56% | LATE 1 | EARLY 1 | RANK #1916 | SPON 3

Nearest open-share peer: Advanced Colorectal Cancer (56% recruiting · 9 trials)

Sleeve Gastrectomy (this)56%Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Sleeve Gastrectomy

Sleeve Gastrectomy lists 5 open slots (56% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sleeve Gastrectomy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sleeve Gastrectomy is recruiting above its size-band peers.

    5 of 9 indexed trials (55.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Sleeve Gastrectomy research.

    Brigham and Women's Hospital accounts for 3 of 9 trials (33.3%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Sleeve Gastrectomy enrolment sits around 88 participants.

    Median target enrolment is 88 among the 9 trials that report a genuine target (sentinel values excluded). 5 of those (55.6%) plan for fewer than 100 participants.

  4. Sleeve Gastrectomy splits between interventional and observational designs.

    5 interventional and 4 observational studies make up this index (55.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 41

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 4 1

Named interventions

Most-linked intervention names on Sleeve Gastrectomy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Venlafaxine IR and Venlafaxine XR Drug
1 trials
Dietary habits Other
1 trials
In-laboratory assessment Other
1 trials
Dietary habits plan Behavioral
1 trials
EndoFLIP measurement Device
1 trials
Roux-en-Y Gastric Bypass Procedure
1 trials
Atropine Drug
1 trials
Exendin-(9-39) Drug
1 trials

US sites by state

Facility locations filed on Sleeve Gastrectomy trials. A trial with sites in several states counts in each.

Massachusetts 3 trials
Texas 2 trials
North Dakota 1 trials
Minnesota 1 trials
Illinois 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sleeve Gastrectomy page

9 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sleeve Gastrectomy condition card totals 9 registered trials; most-linked intervention Venlafaxine IR and Venlafaxine XR; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.